Malignant Mesothelioma

Showing 1 - 25 of 61

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Malignant Peritoneal Mesothelioma, Peritoneal Mesothelioma, Mesothelioma Trial in United States (Pemetrexed, Cisplatin,

Recruiting
  • Malignant Peritoneal Mesothelioma
  • +4 more
  • Chicago, Illinois
  • +10 more
Sep 21, 2023

Epithelioid Sarcoma (Ex-US Only), Spindle Cell Sarcoma, Sinonasal Carcinoma Trial (Tazemetostat)

Temporarily not available
  • Epithelioid Sarcoma (Ex-US Only)
  • +19 more
  • (no location specified)
Oct 17, 2022

Breast Cancer, Glioblastoma, Head and Neck Squamous Cell Carcinoma Trial (PRT3645)

Not yet recruiting
  • Breast Cancer
  • +5 more
  • (no location specified)
Sep 9, 2022

Biological Characteristics of Mesothelioma Patients

Completed
  • Malignant Mesothelioma
    • Rozzano, Milano, Italy
    • +1 more
    Sep 8, 2022

    Non Small Cell Lung Cancer, Non-squamous Non-small-cell Lung Cancer, Urothelial Carcinoma Trial in Augusta (Cabozantinib,

    Recruiting
    • Non Small Cell Lung Cancer
    • +3 more
    • Augusta, Georgia
      Augusta University Georgia Cancer Center
    Mar 6, 2022

    CD30-Positive Neoplastic Cells Present, Malignant Mesothelioma Trial in Houston (Brentuximab Vedotin, Laboratory Biomarker

    Recruiting
    • CD30-Positive Neoplastic Cells Present
    • Malignant Mesothelioma
    • Brentuximab Vedotin
    • Laboratory Biomarker Analysis
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 3, 2022

    Malignant Mesothelioma Trial in United States (pemetrexed disodium, clinical observation)

    Completed
    • Malignant Mesothelioma
    • pemetrexed disodium
    • clinical observation
    • Scottsdale, Arizona
    • +144 more
    Aug 16, 2021

    Liver Cancer, Anxiety Disorder, Depression Trial in United States (Early palliative care)

    Completed
    • Liver Cancer
    • +9 more
    • Early palliative care
    • La Jolla, California
    • +22 more
    Jul 22, 2021

    Advanced Solid Tumours, Cervical Cancer, Malignant Mesothelioma Trial in Shanghai (SG001)

    Recruiting
    • Advanced Solid Tumours
    • +4 more
    • Shanghai, Shanghai, China
      Shanghai East Hospital
    Apr 29, 2021

    Malignant Mesothelioma Trial in Houston (Antineoplaston therapy (Atengenal + Astugenal))

    Terminated
    • Malignant Mesothelioma
    • Antineoplaston therapy (Atengenal + Astugenal)
    • Houston, Texas
      Burzynski Clinic
    Mar 31, 2021

    Lung Cancer, Malignant Mesothelioma, Metastatic Cancer Trial in Los Angeles (radiofrequency ablation)

    Completed
    • Lung Cancer
    • +3 more
    • radiofrequency ablation
    • Los Angeles, California
      Jonsson Comprehensive Cancer Center, UCLA
    Jul 30, 2020

    Malignant Mesothelioma Trial in United States (everolimus)

    Completed
    • Malignant Mesothelioma
    • Tucson, Arizona
    • +128 more
    Feb 19, 2020

    Breast Cancer, Colorectal Cancer, Lung Cancer Trial in Philadelphia (educational intervention, psychosocial assessment and care,

    Completed
    • Breast Cancer
    • +6 more
    • educational intervention
    • +2 more
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center - Philadelphia
    Feb 27, 2020

    Malignant Mesothelioma Trial in Germany, Switzerland (drug, procedure, radiation)

    Completed
    • Malignant Mesothelioma
    • Freiburg, Germany
    • +12 more
    May 13, 2019

    Angiogenesis and Disease in Unresectable Malignant Mesothelioma

    Terminated
    • Malignant Mesothelioma
    • immunoenzyme technique
    • laboratory biomarker analysis
    • (no location specified)
    Jan 22, 2019

    Malignant Mesothelioma Trial in Sutton (bortezomib, cisplatin)

    Completed
    • Malignant Mesothelioma
    • Sutton, England, United Kingdom
      Royal Marsden - Surrey
    Jul 11, 2018

    IP3R Modulation by Cancer Genes in Mesothelioma

    Not yet recruiting
    • Malignant Mesothelioma
    • pleural biopsy
    • (no location specified)
    Jun 5, 2018

    Malignant Mesothelioma Trial in United States (epirubicin HCl, gemcitabine HCl)

    Completed
    • Malignant Mesothelioma
    • epirubicin hydrochloride
    • gemcitabine hydrochloride
    • Mobile, Alabama
    • +23 more
    Dec 5, 2016

    Collecting Tumor Samples From Patients With Gynecological Tumors

    Completed
    • Borderline Ovarian Clear Cell Tumor
    • +85 more
    • Laboratory Biomarker Analysis
    • Fayetteville, Arkansas
    • +186 more
    Oct 26, 2016

    Malignant Mesothelioma Trial in United States (dasatinib)

    Completed
    • Malignant Mesothelioma
    • La Jolla, California
    • +36 more
    Jul 11, 2016

    Malignant Mesothelioma Trial in United States (capecitabine)

    Completed
    • Malignant Mesothelioma
    • Birmingham, Alabama
    • +49 more
    Jul 12, 2016

    Malignant Mesothelioma Trial in United States (PTK787/ZK 222584)

    Completed
    • Malignant Mesothelioma
    • PTK787/ZK 222584
    • Anniston, Alabama
    • +79 more
    Jun 30, 2016

    Leukemia, Lung Cancer, Malignant Mesothelioma Trial in New York (biological, genetic, other)

    Completed
    • Leukemia
    • +4 more
    • WT-1 analog peptide vaccine
    • +5 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Feb 2, 2016

    Malignant Mesothelioma, Pancreatic Cancer, Ovarian Tumor Trial in Beijing (anti-meso-CAR vector transduced T cells)

    Unknown status
    • Malignant Mesothelioma
    • +5 more
    • anti-meso-CAR vector transduced T cells
    • Beijing, Beijing, China
      Biotherapeutic Department and Pediatrics Department of Chinese P
    Oct 19, 2015

    Optical Coherence Tomography of Airway for Lung Cancer or Lung

    Withdrawn
    • Lung Cancer
    • +4 more
    • bronchoscopic and lung imaging studies
    • +3 more
    • Cleveland, Ohio
      Case Medical Center, University Hospitals Seidman Cancer Center,
    Oct 1, 2015